TrialThe Journal of infectious diseases2013

Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.

Livio Azzoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.